VERU INC. — Form 8-K
Filed July 2, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 34/100
What the filing says
On July 2, 2026, Veru Inc. entered into a Sales Agreement with Oppenheimer Co. Inc. and Canaccord Genuity LLC to sell up to $21.8 million of common stock through an at-the-market (ATM) offering. The agents will receive 3.0% compensation on each sale. This provides Veru with a flexible capital-raising mechanism but no immediate cash; proceeds depend on actual share sales at market prices.
Why this rating
ATM program represents ~34% of $64.1M market cap—material financing optionality, but execution-dependent. Routine for small-cap biotech; no immediate dilution or cash received. Standard shelf-registration mechanics.
Extracted items
- 8.01 other event
- 9.01 exhibits
View original filing on SEC.gov ↗
See more from July 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.